Therapeutic oligonucleotides act on different stages of pathological gene expression. Standard schematic of oligonucleotide activities in pathogenesis disease progression. Decoys bind to transcription ...
Heteroduplex oligonucleotide is a brand new oligonucleotide drug. It is found to be significantly potent at reducing expression of the target RNA, and also improves the phenotype in disease models ...
Peptide-based structures can be designed to yield artificial proteins with specific folding patterns and functions. Template-based assembly of peptide units is one design option, but the use of two ...
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Oligonucleotides: Global Markets" report has been added to ResearchAndMarkets.com's offering. The Global Oligonucleotides Market was valued at USD 7 ...
The use of oligonucleotides as therapeutic agents is of great interest, particularly when it comes to siRNA and antisense oligonucleotides. However, the difficulty of targeting the right organ and ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 83, No. 6 (Mar. 15, 1986), pp. 1665-1669 (5 pages) In an effort to understand the relationships among and the ...
Oligonucleotides represent a rapidly growing class of biological therapeutics, poised to revolutionize the treatment landscape for a myriad of diseases. The characterization of these complex ...
Oligonucleotides are a class of nucleic acid molecules consisting of dozens of nucleotides with short sequences. They mainly inhibit the expression of target proteins through gene silencing so as to ...
Toll-like receptor 8 (TLR8) recognizes viral or bacterial single-stranded RNA (ssRNA) and activates innate immune systems. TLR8 is activated by uridine- and guanosine-rich ssRNA as well as by certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback